Commonwealth Pediatrics
Commonwealth Pediatrics was paid $12.58M by Medicaid between Jan 2018 and Dec 2024, across 63 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 37% of everything it billed.
33Billing provider infoCOMMONWEALTH PEDIATRICS
RICHMOND, VA 23225
RICHMOND, VA 23225
33aNPI1104917954assigned 09/27/2006
33bProvider typeSpecialist
28Total paid$12.58M
24GClaims482,769
24DCodes billed63
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Specialist providers in Virginia
Rank by total paid#2 of 231
Median peer was paid$47K
This provider vs. median267×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 47,746 | $1.25M | |
| 2019 | 65,846 | $1.74M | |
| 2020 | 54,319 | $1.36M | |
| 2021 | 65,787 | $1.64M | |
| 2022 | 76,704 | $2.01M | |
| 2023 | 87,162 | $2.29M | |
| 2024incomplete | 85,205 | $2.28M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 37% | 82,928 | 75,372 | $4.65M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 12% | 19,056 | 17,451 | $1.50M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 11% | 20,860 | 18,383 | $1.39M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 10% | 17,578 | 16,428 | $1.27M |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 5.3% | 8,880 | 8,557 | $661K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 3.9% | 14,577 | 13,644 | $493K |
| 90670 | 2.1% | 10,298 | 9,895 | $267K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.9% | 3,008 | 2,891 | $242K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.8% | 19,081 | 8,728 | $229K |
| 90700 | 1.7% | 17,811 | 16,523 | $209K | |
| 90677 | 1.5% | 2,106 | 1,756 | $185K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.3% | 6,058 | 5,513 | $164K |
51 more codes
| 90713 | 1.2% | 11,968 | $149K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 1.2% | 53,859 | $147K |
| 90686 | 1.1% | 12,519 | $133K | |
| 90648 | 1.0% | 12,316 | $128K | |
| 90680 | <1% | 6,075 | $117K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 9,682 | $117K |
| 99173 | <1% | 29,599 | $52K | |
| 90651 | <1% | 1,207 | $50K | |
| 90744 | <1% | 3,968 | $47K | |
| 90716 | <1% | 1,838 | $46K | |
| 90619 | <1% | 696 | $42K | |
| 90633 | <1% | 2,632 | $32K | |
| 90707 | <1% | 1,739 | $32K | |
| 85014 | <1% | 14,278 | $32K | |
| 90461 | <1% | 24,720 | $30K | |
| 99381 | <1% | 398 | $26K | |
| 96161 | <1% | 26,726 | $23K | |
| 81002 | <1% | 5,769 | $15K | |
| 99177 | <1% | 4,536 | $15K | |
| 90656 | <1% | 932 | $14K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 1,572 | $12K |
| 99188 | <1% | 598 | $11K | |
| 87807 | <1% | 764 | $8K | |
| 96127 | <1% | 4,341 | $8K | |
| 0071A | <1% | 150 | $5K | |
| 36416 | <1% | 20,480 | $4K | |
| 0072A | <1% | 125 | $4K | |
| 90480 | <1% | 199 | $3K | |
| 90734 | <1% | 153 | $3K | |
| 90715 | <1% | 176 | $3K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 2,256 | $3K |
| 90380 | <1% | 22 | $3K | |
| 92551 | <1% | 255 | $2K | |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 2,211 | $2K |
| 90621 | <1% | 44 | $2K | |
| 0001A | <1% | 34 | $1K | |
| 90688 | <1% | 62 | $696.20 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 81 | $617.83 |
| 0002A | <1% | 16 | $486.00 | |
| 87428 | <1% | 29 | $485.46 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 44 | $290.60 |
| 97802 | <1% | 481 | $275.39 | |
| 96380 | <1% | 14 | $198.05 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 16 | $124.32 |
| 99051 | <1% | 69 | $115.03 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 12 | $10.20 |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | <1% | 60 | $7.49 |
| 91307 | <1% | 600 | $4.54 | |
| 91300 | <1% | 175 | $1.69 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 20 | $0.89 |
| 91308 | <1% | 12 | $0.02 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSTHREHLER, PAUL (PARTNER OF PRACTICE)